What causes relapses of autoimmune diseases? The etiological role of autoreactive T cells

Autoimmunity Reviews

Volumn 12, Issue 11, 2013, Pages 1070-1075

  Wildner, Gerhild ^a   Kaufmann, Ulrike ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cytokines; IFN gamma; Rat model; Signaling transduction pathways; Uveitis

Indexed keywords

AUTOANTIGEN; GAMMA INTERFERON; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; SONIC HEDGEHOG PROTEIN; STAT PROTEIN; TRANSCRIPTOME; WNT PROTEIN;

ADOPTIVE TRANSFER; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; AUTOIMMUNE UVEITIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; DISEASE COURSE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HELPER CELL; IMMUNIZATION; INFLAMMATION; MIGRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RELAPSE; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL; T LYMPHOCYTE; UPREGULATION;

ACTG2; ACTIN GAMMA 2; C-JUN N-TERMINAL PROTEIN KINASE/MITOGEN-ACTIVATED PROTEIN KINASE 9; CASP; CASPASE; CATHEPSIN C; CATHEPSIN H; CNKSR1/MAGI1; CONNECTOR ENHANCER OF KINASE SUPPRESSOR OF RAS 3/MEMBRANE-ASSOCIATED GUANYLATE KINASE-INTERACTING PROTEIN-LIKE 1; CTSC; CTSH; CYTOKINES; E-CADHERIN; EAU; ECAD; ERK; EXPERIMENTAL AUTOIMMUNE UVEITIS; EXTRACELLULAR SIGNAL-REGULATED KINASE; GLI1; GLIOMA-ASSOCIATED ONCOGENE HOMOLOG 1; GRANZYME G; GZMG; HEDGEHOG; HH; HLA-DMB; IFN-GAMMA; INTERFERON GAMMA-INDUCED PROTEIN 10/INTERFERON-INDUCIBLE CYTOKINE 10; INTERPHOTORECEPTOR RETINOID-BINDING PROTEIN; IP-10/CXCL10; IRBP; JAG1; JAGGED 1; JAK/STAT; JAK2; JANUS KINASE 2; JANUS KINASE/SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; JNK2/MAPK9; LEF1; LYMPHOID ENHANCER-BINDING FACTOR 1; MACROPHAGE MIGRATION INHIBITORY FACTOR; MAGUK; MAPK; MEMBRANE-ASSOCIATED GUANYLATE KINASE; MHC CLASS II DM BETA; MIF; MITOGEN-ACTIVATED PROTEIN KINASE; NAD(P)H:QUINONE OXIDOREDUCTASE 1; NFΚB; NQO1; NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS; PCP; PLANAR CELL POLARITY; QPCR; QUANTITATIVE REAL TIME POLYMERASE CHAIN REACTION; RAB27A; RALGPS2; RAS-RELATED PROTEIN 27A; RAS-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 2; RAT MODEL; RT1 CLASS II LOCUS DA; RT1.DA; SHH; SIGNALING TRANSDUCTION PATHWAYS; SONIC HEDGEHOG; T CELL FACTOR 1; TCF-1; TGM2; TRANSGLUTAMINASE 2; UVEITIS;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; RATS; RATS, INBRED LEW; RECURRENCE; UVEITIS;

EID: 84881548127     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.04.001     Document Type: Review

References (44)

1. Diedrichs-Möhring M., Hoffmann C., Wildner G. Antigen-dependent monophasic or recurrent autoimmune uveitis in rats. Int Immunol 2008, 20:365-374.
2. von Toerne C., Sieg C., Kaufmann U., Diedrichs-Mohring M., Nelson P.J., Wildner G. Effector T cells driving monophasic vs. relapsing/remitting experimental autoimmune uveitis show unique pathway signatures. Mol Immunol 2010, 48:272-280.
3. Rowbotham N.J., Hager-Theodorides A.L., Furmanski A.L., Crompton T. A novel role for Hedgehog in T-cell receptor signaling: implications for development and immunity. Cell Cycle 2007, 6:2138-2142.
4. Orsulic S., Huber O., Aberle H., Arnold S., Kemler R. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 1999, 112(Pt 8):1237-1245.
5. Dobrosotskaya I.Y., James G.L. MAGI-1 interacts with beta-catenin and is associated with cell-cell adhesion structures. Biochem Biophys Res Commun 2000, 270:903-909.
6. Patrie K.M., Drescher A.J., Welihinda A., Mundel P., Margolis B. Interaction of two actin-binding proteins, synaptopodin and alpha-actinin-4, with the tight junction protein MAGI-1. J Biol Chem 2002, 277:30183-30190.
7. Dobrosotskaya I., Guy R.K., James G.L. MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domains. J Biol Chem 1997, 272:31589-31597.
8. Ziera T., Irlbacher H., Fromm A., Latouche C., Krug S.M., Fromm M., et al. Cnksr3 is a direct mineralocorticoid receptor target gene and plays a key role in the regulation of the epithelial sodium channel. FASEB J 2009, 23:3936-3946.
9. Kaufmann U., Diedrichs-Mohring M., Wildner G. Dynamics of intraocular IFN-gamma, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis. PLoS One 2012, 7:e49008.
10. Alam A., Cohen L.Y., Aouad S., Sekaly R.P. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 1999, 190:1879-1890.
11. Puga I., Rao A., Macian F. Targeted cleavage of signaling proteins by caspase 3 inhibits T cell receptor signaling in anergic T cells. Immunity 2008, 29:193-204.
12. + T cells. J Immunol 2002, 169:5451-5457.
13. Lowrey J.A., Stewart G.A., Lindey S., Hoyne G.F., Dallman M.J., Howie S.E., et al. Sonic hedgehog promotes cell cycle progression in activated peripheral CD4(+) T lymphocytes. J Immunol 2002, 169:1869-1875.
14. Weijzen S., Velders M.P., Elmishad A.G., Bacon P.E., Panella J.R., Nickoloff B.J., et al. The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J Immunol 2002, 169:4273-4278.
15. Kim S.Y., Jeong E.J., Steinert P.M. IFN-gamma induces transglutaminase 2 expression in rat small intestinal cells. J Interferon Cytokine Res 2002, 22:677-682.
16. Fesus L., Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002, 27:534-539.
17. Chhabra A., Verma A., Mehta K. Tissue transglutaminase promotes or suppresses tumors depending on cell context. Anticancer Res 2009, 29:1909-1919.
18. + T cells to Th1 cells requires MAP kinase JNK2. Immunity 1998, 9:575-585.
19. Shen G., Jeong W.S., Hu R., Kong A.N. Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents. Antioxid Redox Signal 2005, 7:1648-1663.
20. Chen D., Chan R., Waxman S., Jing Y. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors. Cancer Res 2006, 66:11416-11423.
21. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91.
22. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
23. + lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?. Blood 1995, 86:651-658.
24. + regulatory T cells. Nat Immunol 2003, 4:330-336.
25. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007, 19:345-354.
26. + T cells in rat models of uveitis analyzed by intravital fluorescence microscopy and FACS. Int Immunol 2004, 16:1573-1582.
27. Miyara M., Gorochov G., Ehrenstein M., Musset L., Sakaguchi S., Amoura Z. Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 2011, 10:744-755.
28. Nie H., Zheng Y., Li R., Guo T.B., He D., Fang L., et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat Med 2013, 19:322-328.
29. Cooney L.A., Towery K., Endres J., Fox D.A. Sensitivity and resistance to regulation by IL-4 during Th17 maturation. J Immunol 2011, 187:4440-4450.
30. Higashi T., Hashimoto K., Takagi R., Mizuno Y., Okazaki Y., Tanaka Y., et al. Curdlan induces DC-mediated Th17 polarization via Jagged1 activation in human dendritic cells. Allergol Int 2010, 59:161-166.
31. Di Cesare A., Di Meglio P., Nestle F.O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009, 129:1339-1350.
32. Vogel C.F., Goth S.R., Dong B., Pessah I.N., Matsumura F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun 2008, 375:331-335.
33. Sasaki Y., Mita H., Toyota M., Ishida S., Morimoto I., Yamashita T., et al. Identification of the interleukin 4 receptor alpha gene as a direct target for p73. Cancer Res 2003, 63:8145-8152.
34. Sasaki Y., Ishida S., Morimoto I., Yamashita T., Kojima T., Kihara C., et al. The p53 family member genes are involved in the Notch signal pathway. J Biol Chem 2002, 277:719-724.
35. Jones E.V., Dickman M.J., Whitmarsh A.J. Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase. Biochem J 2007, 405:617-623.
36. Gansbacher B., Zier K.S. HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium. Clin Exp Immunol 1989, 76:440-445.
37. Taams L.S., van Eden W., Wauben M.H. Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions. Eur J Immunol 1999, 29:1543-1550.
38. Sabzevari H., Kantor J., Jaigirdar A., Tagaya Y., Naramura M., Hodge J., et al. Acquisition of CD80 (B7-1) by T cells. J Immunol 2001, 166:2505-2513.
39. Leng L., Metz C.N., Fang Y., Xu J., Donnelly S., Baugh J., et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003, 197:1467-1476.
40. Commodaro A.G., Bueno V., Belfort R., Rizzo L.V. Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation. Autoimmun Rev 2011, 10:205-209.
41. Maiti A.K., Nath S.K. Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy. Autoimmun Rev 2013, 12:510-522.
42. Gatto M., Zen M., Ghirardello A., Bettio S., Bassi N., Iaccarino L., et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 2013, 12:523-536.
43. Rizzo L.V., Xu H., Chan C.C., Wiggert B., Caspi R.R. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol 1998, 10:807-814.
44. O'Garra A., Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007, 7:425-428.